You just read:

The FDA has Accepted an Orphan Designation Request for use of Truveta Administered Intranasally Submitted by Axium Pharmaceuticals Inc.

News provided by

Axium Pharmaceuticals Inc.

Jul 11, 2017, 08:35 ET